Pierre Kory interviewed on The New American, talks about vax injury treatment

Hydroxychloroquine / Plaquenil, which is a second-line drug on the FLCCC protocol, is more of a first-line drug for him.

He notes that patients respond very differently to each treatment. One may work wonders for a patient, not work at all for another.